• Ac-YVAD-CMK for Reliable Pyroptosis Assays

  2026-09-17

  Learn how Ac-YVAD-CMK (SKU C4810) can help separate caspase-1-dependent cytokine maturation from membrane injury in viability, inflammation, and pyroptosis assays. This scenario-based guide covers controls, formulation, interpretation, and practical product-selection criteria.

• MK-8745: A Context-Aware Aurora A Workflow

  2026-09-16

  MK-8745 is a potent and selective Aurora A inhibitor for dissecting mitotic control, apoptosis, and tumor vulnerability. This article translates retinoblastoma findings into practical assay decisions across cell-based and xenograft research while clarifying model selection, endpoint timing, and interpretation limits.

• Chicken Gasdermins Reveal Caspase-Driven Pyroptosis

  2026-09-16

  The reference study defines a previously undercharacterized avian pyroptosis pathway by showing that chicken gasdermin A and gasdermin E are cleaved by distinct caspases and that their amino-terminal fragments can damage membranes and restrict bacterial growth. Its combination of biochemical cleavage mapping, cell-based pore-function assays, and infection models provides a framework for studying species-specific gasdermin biology while highlighting the limits of directly transferring mammalian inflammasome models to birds.

• Auranofin and Metabolic Stress in HCC Research

  2026-09-15

  Auranofin is a thioredoxin reductase inhibitor that can help researchers interrogate the relationship between redox control and metabolic plasticity in hepatocellular carcinoma. This article translates recent FOXO3/YAP findings into a rigorous, redox-aware assay strategy without overstating unvalidated mechanisms.

• CHIR-99021 for Stem Cell and Organoid Workflows

  2026-09-15

  CHIR-99021 (CT99021) provides reversible, selective GSK-3α/β control for tuning pluripotency, endodermal patterning, and organoid maturation. This guide translates atlas-based developmental benchmarking into practical dosing, assay design, and troubleshooting strategies.

• CCG-1423: A Pathway-Resolved Assay Strategy

  2026-09-14

  CCG-1423 is a RhoA inhibitor that helps separate MRTF-A transcriptional signaling from ROCK-dependent cytoskeletal remodeling. This article translates recent RhoA/ROCK pathway findings into a practical, evidence-aware framework for cancer research, apoptosis assay design, and cross-domain interpretation.

• BAX–BAK Mosaic Rings in Apoptotic Mitochondria

  2026-09-14

  The reference study uses live- and fixed-cell STED microscopy to show that endogenous BAX and BAK assemble into heterogeneous mosaic rings on apoptotic mitochondria, rather than a uniform oligomeric structure. Its findings place BAK recruitment slightly ahead of BAX and show why endogenous protein measurements are essential for interpreting mitochondrial outer membrane permeabilization.

• Aging Lens Epithelium and Ferroptosis Susceptibility

  2026-09-13

  Wei and colleagues show that aging lens epithelial cells become unusually vulnerable to ferroptosis, linking age-related redox imbalance, lipid peroxidation, iron accumulation, and impaired glutathione protection. Their combination of human and mouse models, glutathione perturbation, RSL3 and erastin exposure, and transcriptome analysis provides a mechanistic framework for studying ferroptosis in cataractogenesis.

• WEHI-539: A BCL-XL Inhibitor Workflow

  2026-09-12

  WEHI-539 is a selective BCL-XL inhibitor for separating BCL-XL dependence from broader apoptotic stress. This practical guide connects dose-response testing, mitochondrial apoptosis assays, cancer stem cell sensitization, and MCL-1-focused combination studies.

• 1-methyl Adenosine Assay Workflows

  2026-09-11

  Build reliable 1-methyl Adenosine workflows for cell perturbation, intracellular nucleoside profiling, and biomarker discovery. The practical strategy combines controlled dosing with stable isotope-diluted UHPLC–MS/MS, chromatographic isomer separation, and matrix cleanup.

• MK-571 Workflows for Inflammation Research

  2026-09-11

  MK-571 (L-660,711) helps separate cysteinyl leukotriene signaling from ABCC1/MRP1-linked drug transport in airway and macrophage assays. This practical guide covers assay setup, dosing logic, cross-model controls, and troubleshooting for bronchoconstriction, allergic inflammation, and chemotherapy-stress workflows.

• RSL3 Workflows for GPX4-Driven Ferroptosis

  2026-09-10

  RSL3 provides a fast, mechanistically focused way to test GPX4-dependent ferroptosis, from HCC pathway studies to RAS-driven cancer models. This guide combines practical handling, quantitative assay conditions, TEAD2-informed experimental design, and troubleshooting for more reproducible oxidative cell-death results.

• Schizophrenia Risk Pathways in Developing Neurons

  2026-09-10

  Liu et al. used cell-type-resolved human iPSC models to show that schizophrenia-associated loci converge on different developmental pathways in cortical interneurons and glutamatergic neurons. The study links interneuron risk loci to PKC hyperactivity and arborization defects, while glutamatergic-neuron loci affect ion transport and calcium currents, providing a framework for cell-specific mechanistic studies.

• Amiloride (MK-870) for Ion Transport Workflows

  2026-09-09

  Amiloride (MK-870) enables controlled perturbation of epithelial sodium transport, with practical value in sodium channel research, cystic fibrosis research, and hypertension research. Its negative result in a reovirus-entry study also makes it a useful specificity control when testing cellular endocytosis modulation rather than a presumed universal uptake inhibitor.

• SM-164: Reliable Apoptosis Assay Workflows

  2026-09-09

  This scenario-based guide explains how SM-164 (SKU A8815), a bivalent Smac mimetic, can support interpretable viability, proliferation, and apoptosis experiments. It covers mechanism, solvent compatibility, handling, orthogonal readouts, and practical criteria for selecting a reliable research reagent.

550 records 4/37 page Previous Next 12345 下5页 Last page